Introduction
RCM (Rhinocerebral mucormycosis) is also known as phacomycosis or zygomycosis, is a rare fatal opportunistic infection caused by the family of mucoraceae (Mucor, Rhizomucor, Rhizopus, Absidia species) that are commonly found in soil and among decaying vegetation 1, 2 . RCM is usually seen in diabetics, especially in ketoacidosis, but may also appear in healthy people 3 . Several clinical forms are described such as rhino-orbital-cerebral, pulmonary, sdisseminated, cutaneous, and gastrointestinal. Rhino-orbital-cerebral is the most common form in diabetic patients 4 . Initially majority of patients complain about the typical symptoms of acute bacterial rhinosinusitis but they deteriorate rapidly and do not respond to conventional treatment, such patients are usually associated with diabetic
Rhino Cerebral Mucormycosis with Post Surgical Complications in
Diabetes: A Case Report report of tissue from right maxillary antrum and pterygopalatine fossa showed chronic inflammation and foci of necrosis with fungal hyphae. This time the patient was treated with Posaconazole.
In the mean time on 6th July 2015, patient again complain of high grade fever and headache since 5 days with H/O vomiting for 2 days and bilateral leg swelling for 2 days. He also complained of reduce amount of urine but no dysurea. At that time patient's mental status also deteriorate. 
Examination of eyes:
Left eye-Anterior segment-NAD, Pupil-reacting, Fundus-Diabetic retinopathy. Right eye-An-ophthalmic socket, enucleation. Eye lid-upper eye lid defected about 1.5cm x1.5cm, both eyelid were adherent at the margin. Orbital surface-unhealthy tissue occupying whole of the surface with defect in the apex of the orbit which was 1 cm x1 cm continuous with the sphenoidal surface and advised for clean and dressing daily with anti-fungal eye drop and collection of orbital surface exudate for culture and sensitivity.
Tube thoracostomy done on 4.8.15 at left 6th intercostal space posterior to anterior axillary fold. 900 ml blood was evacuated and advice for gradual decompression, unclamping for 5-6 seconds and occurs in the maxillofacial region, there are only few reported cases of RM in the mandible. 6, 17 Radiographically, maxillary mucormycosis typically shows opacification of the paranasal sinuses without fluid level, thickening of the sinus mucosa and bone distraction of the sinus walls [ Figure: 7& 8]. As some of these radiographic features may resemble sinusitis, McDonogh et al. warned that any diabetic patient in a ketoacidotic state presenting with clinical and radiographic features of rhinosinusitis should be suspected as having mucormycosis until proven otherwise 21 .
Definitive diagnosis of RM is usually obtained by a tissue biopsy which identifies the characteristic hyphae. 18 Histologically, mucormycosis is characterised by extensive tissue necrosis and the presence of numerous, large (5-30 mm), thinned-wall fungal hyphae, which are non-septate, branched at right angles and have a ribbon-like appearance [ Figure: 9].
Successful management of rhinocerebral mucormycosis includes both medical and surgical modalities. The initial medical approach to mucormycosis consists of aggressive treatment of the underlying predisposing medical condition and the use of systemic antifungal agents. The use of amphotericin B in patients with mucormycosis has been widely published and accepted as the best form of treatment with an overall survival rate of up to 72%. 15, 16, 18 Based on recent published data, Spellberg et al. highlighted the recommended use of liposomal amphotericin B such as Am Bisome in the management of mucormycosis. 22 Surgical management is crucially important and should involve early debridement of all infected and necrotic tissues. This may have to be repeated based on progression of the disease. In some cases, radical resection may be required, which can include partial or total maxillectomy, mandibulectomy and orbital exenteration. 13, 23 Reddy S Sujatha et al reported two cases of rhinocerebral mucormycosis in two uncontrolled diabetic patients with deep palatal perforation in one case and this was a rare and late occurrence. Both the patients were successfully treated with a combination of surgical debridement and systemic Amphotericin B administration. 24 Hyperbaric oxygen(HBO)treatments should also be considered for those patients with aggressive involved. 12, 13, 14 Amongst the paranasal sinuses, the most frequently involved are the maxillary and ethmoid sinuses.11 RCM is the most common form in patients with DKA(Diabetic ketoacidosis). 16 Patients with rhinocerebral mucormycosis usually present with malaise, headache, facial pain, swelling and low grade fever. 15 Rhino cerebral mucormycosis usually begins in the nasal mucosa or palate and extends to the paranasal sinuses, spreading via the angular, lacrimal, and ethmoid vessels as well as by direct extension from the sinuses into the retro-orbital region. Once fungal hyphae enter into the blood stream they can disseminate to other organs such as cerebrum or lungs which can be fatal for the patient. Mucor hyphae form thrombi within the blood vessels which reduce vascularity to the tissues and cause necrosis 17 . With orbital involvement, function of the cranial nerves II, III, IV and VI may be lost or impaired, with resultant proptosis, ptosis, papillary dilation, visual loss as well as periorbital cellulitis. Typical clinical presentation includes facial pain, presence of an irregular black eschar on the palatal or nasal mucosa and drainage of pus from the eye and nose 18 .
In our case we have shown a male diabetic patient with poorly controlled diabetes mellitus who developed rhinocerebral mucormycosis with post surgical meningitis, haemothorax, type I respiratory failure with acute kidney injury. Ya-Chun Hsiao, Kun-Wu Tsan and Tao-Yeuan Wang, 2002, reported a female diabetic patient with poorly controlled blood sugar who developed rhinocerebral mucormycosis typically present with malaise, retro orbital headache, fever and occasionally dark blood tinged rhinorrhoea 19 . Vinay Vaidyanathan and Kishore Shetty, 2012, reported a series of 3 cases of rhinocerebral mucormycosis, in which 2 cases were successfully treated with Amphotericin B and one developed tubercular meningitis with obstructive hydrocephalus and the patient developed high morbid state 20 . In our case the patient developed meningitis 3 times and was successfully treated with broad spectrum antibiotics. Kim et al. (2001) reported 4 cases of RM over a period of ten years, which were diagnosed postdental extractions. In all these 4 cases, the patients had an uncontrolled DM with two of them in a DKA state at the time of presentation 15 . Even though mucormycosis of the head and neck commonly
Discussion
Mucormycosis is a fungal infection caused by a member of the family Mucoraceae.
Rhizopus, Mucor, Absidia are the most common isolated from patients with mucormycosis. Rhizopus is responsible for 60% of all cases of mucormycosis, and 90% of rhinocerebral mucormycosis 6, 7 . The fungi are found in soil, bread, mold, rotten fruits and vegetables. Though mucormycosis is ubiquitous and grows rapidly, it seldom strikes in immunologically competent patients. Therefore, if an infection with mucormycosis occurs, it usually indicates a serious underlying medical condition. The risk factors for developing rhinocerebral mucormycosis include severe burn, acquired immune deficiency syndrome (AIDS), immunosuppressive medications, leukemia, diabetes mellitus, and organ transplantation 8 . About 70% to 80% of these patients have diabetes mellitus. As is reported in our case, most diabetics who develop rhinocerebral mucormycosis (RCM) are in poor metabolic control with complicating ketoacidosis 9 . It is suggested that fungal organism grows in ketotic patients because acidosis disrupts iron binding to transferring and the result increases in free iron then promotes growth of the fungus. At the same time, high blood sugar level may also alter the immunologic capability to resist mucormycosis through reduction of WBC chemotaxis and the ability of macrophages 10 .
Baker introduced the term ''rhinocerebral mucormycosis'' as a malignant form of cephalic mucormycosis with a high mortality rate. In 1958 Chick et al, demonstrated the effectiveness of amphotericin B. Today, the most commonly chosen therapy consists of the treatment of predisposing diseases, radical surgery, and systemic antifungal medication, especially with amphotericin B. Despite these aggressive therapeutic measures the mortality continues to be very high. 1 There are at least six clinical forms of mucormycosis:
rhinocerebral, pulmonary, gastrointestinal, cutaneous, central nervous system, disseminated and miscellaneous, occurring at specific organ sites e.g. kidney and liver. 11, 12, 15 The term rhinocerebral mucormycosis (RCM) should be used when the paranasal sinuses, orbit and brain are Photomicrograph from retro-molar region showing elongated, broad, non-septate branching hyphae within the tissue and the bone marrow space (Gomori methenamine silver nitrate stain, original magnification _400) infections. A few studies have shown that HBO has direct in vitro fungistatic activity and reduce tissue hypoxia, which may reverse the hypoxic acidosis that helps the fungi to proliferate 25 . Blitzer and Lawson found that in their review of 170 cases of RCM, 63% of untreated diabetics died as compared with 17% mortality rate when therapy included aggressive surgery and amphotericin B administration9. The importance of surgery is pronounced when no surgical treatment or only biopsy was performed the mortality rate is as high as 58% 9 .
In our reported case, the management was started early in the course of disease and involved aggressive local debridement with repeated antiseptic packing until the wound healed with healthy granulation tissue. In addition, the correction of the underlying medical condition, along with the use of liposomal amphotericin B therapy, resulted in good control of the disease with a favourable outcome in initial stage. Post surgical complications were managed accordingly. Rehabilitation or closure of the orbital socket and maxillary hole can be done surgically or by construction of a prosthetic appliance.
Conclusion
Mucormycosis is a rapidly progressive disease with a fulminant course and fatal outcome unless diagnosed early and treated rapidly. Prognosis is dependent on multiple factors and early initiation of treatment is an important element. A multidisciplinary approach consisting of neurologist, dental specialists, ENT surgeons, ophthalmologists and nephrologist is critical in successful management of a patient with mucormycosis.
